1. Griffin JE, McPhaul MJ, Russell DW,Wilson JD. The androgen resistance syndromes: steroid 5reductase 2 deficiency, testicular feminization, and related disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Diseases, 7th ed., vol. II. McGraw-Hill, New York, 1995, pp. 2967–2998.
2. Wilson JD. Role of dihydrotestosterone in androgen action. Prostate Suppl 1996; 6: 88–92.
3. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995; 16: 271–321.
4. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P. The nuclear receptor superfamily the second decade. Cell 1995; 83: 835–839.
5. Lubahn DB, Joseph DR, Sar M, Tan J, Higgs HN, Larson RE, French FS, Wilson EM. The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 1988; 2: 1265–1275.